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BCG vaccination prevents pneumonia in immobile elderly patients 
Sir—Delayed-type hypersensitivity (DTH) responses to tuberculin, as described by 
Gillian Black and colleagues1 in Malawi and the UK, is an important marker of T-helper-
1- mediated acquired immunity.2  Since depressed DTH response is associated with 
increased susceptibility to pneumonia and mortality in older people,
3,4 we investigated 
whether BCG vaccination lowers the rate of pneumonia in immobile elderly patients in 
Japan.  
We prospectively assessed the rate of pneumonia in elderly people with a negative 
tuberculin response and no vaccination, in those with a positively converted tuberculin 
response by BCG vaccination, and in those with a naturally positive tuberculin response.  
Patients were selected from three long-term care facilities; those eligible were immobile 
and had a history of stroke.  We excluded patients if they were immunocompromised—
eg, patients who had active malignant disease, renal dialysis, corticosteroids treatment, 
or HIV-1 infection.  All participants had a history of a positive DTH response to 
tuberculin according to their medical records, but were free from active lesions of 
tuberculosis during the study.  They had received influenza vaccination every year, but 
none had received pneumococcal vaccination.  
Before the study, all participants underwent physical examination, chest radiography, 
and tuberculin skin test.2  We enrolled 164 patients in April, 1999, and investigated all 
patients for 2 years.  Pneumonia was diagnosed by two radiologists who were not 
involved in the studies.  
Nine patients were excluded from the analysis because they died from causes other 
than pneumonia during follow-up.  Of the remaining 155 patients, 67 had positive DTH 
responses to tuberculin.  The other 88 patients were randomly assigned by random 
numbers table BCG inoculation (44) or no inoculation (44).  4 weeks after vaccination, 
the negative tuberculin responses converted to positive in 41 (93%) of 44 patients 
inoculated with BCG.  There were no significant differences in the mean age and mean 
scores for activities of daily living
5 between groups.  
During follow-up, new pneumonia was diagnosed in 19 (43%) of the 44 non-inoculated 
patients, six (15%) of the 41 inoculated patients who became tuberculin positive, and nine 
(13%) of the 67 patients with positive DTH responses to tuberculin.  According to Cox’s 
regression model, the relative risk of developing pneumonia in the non-inoculated group 
compared with the inoculated tuberculin-converted patients was 3·22 (95% CI 1·03–9·96, 
p=0·03).  The risk of developing pneumonia did not differ between the tuberculin-
converted group and the positive DTH response group.  
Our findings suggest that BCG inoculation could reactivate the depressed T-helper-1-
mediated cellular immunity and prevent pneumonia in immobile elderly patients with 
previous strokes.  BCG inoculation may, therefore, have beneficial effects on the 
prevention of pneumonia in these patients.  
Katsutoshi Nakayama, Mitsutoshi Shinkawa, Takashi Ohrui, Hisao Hirai, *Hidetada 
Sasaki 
Department of Geriatric and Respiratory Medicine, Tohoku University School of 
Medicine, Sendai 980-8574, Japan 
(e-mail: dept@geriat.med.tohoku.ac.jp)  
1 Black GF, Weir RE, Floyd S, et al. BCG-induced increase in interferon-gamma 
response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and 
the UK: two randomised controlled studies. Lancet 2002; 359: 1393-401.  
2 Shirakawa T, Enomoto T, Shimazu S, Hopkin JM. The inverse association between 
tuberculin responses and atopic disorder. Science 1997; 275: 77-79.  
3 Nakayama K, Monma M, Fukushima T, Ohrui T, Sasaki H. Tuberculin responses and 
risk of pneumonia in immobile elderly patients. Thorax 2000; 55: 867-69.  
4 Roberts-Thomson IC, Whittingham S, Youngchaiyud U, Mackay IR. Ageing, immune 
response, and mortality. Lancet 1974; 2: 368-70.  
5 Katz S, Downs TD, Cash HR, Grotz RC. Progress in development of the index of ADL. 
Gerontologist 1970; 10: 20-30.  
 
Lancet 2002; 360: 1335. 
